Viewing Study NCT03884556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-05-25 @ 5:28 AM
Study NCT ID: NCT03884556
Status: COMPLETED
Last Update Posted: 2025-07-02
First Post: 2019-03-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Sponsor: Trishula Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Metastatic Solid Tumors View
None Advanced Solid Tumors View
None Relapsed/Refractory Lymphoma View
None Prostrate Cancer View
None Pancreatic Cancer View
None Monotherapy View
None Combination Therapy View
None CD39 View
None Adenosine Pathway View
None Immunotherapy View
None Immuno-oncology View
None PD-1 View
None Checkpoint Inhibitor View
None Nab-paclitaxel View
None Gemcitabine View
None Pembrolizumab View
None Docetaxel View
None Bladder Cancer View
None Lung Cancer View